Cost-Effectiveness of Statin Prioritisation Based on Absolute Risk Reduction For Primary Prevention of Cardiovascular Disease

Abstract

Authors

CN Kohli-Lynch AE Moran G Thanassoulis AD Sniderman Y Zhang M Pencina MJ Pletcher E Vittinghoff